NASDAQ
Arno Therapeutics, Inc. (ARNI) has a free cash flow growth of 32.13% as of Friday, May 29, 2026. This represents a 330.23% increase compared to its 12-month average of 7.47%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.